SymBio
Home
Site map
Inquiry
Japanese
  • Vision
  • Management Strategy
  • Pipeline
  • Company Profile
  • CSR
  • IR Infomation
  • SymBio's Vision
  • Company Profile
  • IR Information

Product Information(Japanese)

Contact Us
for Business Opportunity

News & Topics Past News
2012.05.15
Onconova Advances Oral Rigosertib to Phase II Clinical Trial in Myelodysplastic Syndromes
2012.05.11
Financial Results for the First Quarter of Fiscal Year Ended December 31, 2012 [Japan GAAP] (Non-consolidated)
2012.04.16
SymBio Announces Presentation at BioCentury Future Leaders in the Biotech Industry Conference
2012.03.29
Clinical Trial Notificaation Accepted for SymBio's Japan Phase 1 Trial of Rigosertib(SyB L-1101) in Refractory/Relapsed MDS
SymBio Pharmaceuticals Limited

Terms of Use | Privacy Policy

©2012 SymBio Pharmaceuticals Limited. All rights reserved.